Solesence, Inc. balance sheet
At the end of fiscal 2025, Solesence, Inc. had total assets of $46.5m and shareholders' equity of $14.1m. It held $1.3m in cash against $14.3m of debt: net debt of $13.0m.
Balance sheet
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 6 | 3 | 4 | 3 | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
| Receivables | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 3 | 4 | 5 | 3 | 5 | 7 | 9 |
| Inventory | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 6 | 9 | 10 | 20 | 15 | 13 |
| Total current assets | 9 | 5 | 7 | 5 | 4 | 3 | 3 | 5 | 5 | 5 | 9 | 12 | 17 | 16 | 29 | 25 | 25 |
| Total assets | 13 | 9 | 10 | 7 | 6 | 5 | 5 | 6 | 7 | 9 | 14 | 28 | 34 | 33 | 50 | 47 | 46 |
| Accounts payable | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 4 | 6 | 6 | 9 | 4 | 5 |
| Deferred revenue (current) | — | — | — | — | — | — | — | — | 0 | 0 | 0 | 1 | 2 | 2 | 6 | 1 | 2 |
| Total current liabilities | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 4 | 7 | 7 | 14 | 16 | 26 | 14 | 26 |
| Short-term debt | — | — | — | — | — | — | — | — | — | 1 | 1 | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | 1 | 1 | 1 | — | — | — | — |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 7 | 8 | 7 | 14 | 13 |
| Shareholders' equity | 10 | 7 | 8 | 5 | 4 | 3 | 3 | 3 | 1 | 2 | 3 | 7 | 6 | 2 | 10 | 14 | 13 |
| Net debt (negative = net cash) | −6 | −3 | −4 | −3 | −2 | −1 | −2 | −2 | −1 | −0 | 1 | 2 | 5 | 6 | 6 | 13 | 12 |
| Shares outstanding | 21m | 21m | 28m | 28m | 29m | 29m | 31m | 34m | 34m | 38m | 38m | 49m | 49m | 50m | 70m | 71m | 71m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 9 | 5 | 9 | 11 | 10 | 7 | 6 | 9 |
| Inventory | 15 | 20 | 22 | 20 | 19 | 15 | 14 | 13 |
| Total current assets | 30 | 29 | 36 | 39 | 33 | 25 | 23 | 25 |
| Total assets | 48 | 50 | 57 | 60 | 54 | 47 | 44 | 46 |
| Accounts payable | 7 | 9 | 9 | 7 | 5 | 4 | 5 | 5 |
| Deferred revenue (current) | 6 | 6 | 5 | 2 | 1 | 1 | 1 | 2 |
| Total current liabilities | 23 | 26 | 33 | 23 | 18 | 14 | 13 | 26 |
| Shareholders' equity | 15 | 10 | 11 | 14 | 17 | 14 | 13 | 13 |
| Shares outstanding | 70m | 70m | 70m | 70m | 71m | 71m | 71m | 71m |
Compare with peers
- Fitlife Brands, Inc. balance sheet
- Natural Health Trends Corp balance sheet
- Axil Brands, Inc. balance sheet
- Mannatech Inc balance sheet
- Cbdmd, Inc. balance sheet
Head to head: FTLF vs SLSNNHTC vs SLSNAXIL vs SLSN
More: Personal Care Products stocks compared, Consumer Staples sector, rankings of US companies